journal article·2018-02-20Open access

Impact of the Formulation Pathway on the Colloidal State and Crystallinity of Poly-ε-caprolactone Particles Prepared by Solvent Displacement

Carlotta Pucci, Fabrice Cousin, François Dole, Jean-Paul Chapel, Christophe Schatz

Langmuir· Volume 34· Issue 7

Abstract

The formulation pathway and/or the mixing method are known to be relevant in many out-of-equilibrium processes. In this work, we studied the effect of the mixing conditions on the physicochemical properties of poly-ε-caprolactone (PCL) particles prepared by solvent displacement. More specifically, water was added in one shot (fast addition) or drop by drop to PCL solution in tetrahydrofuran (THF) to study the impact of the mixing process on particle properties including size, stability, and crystallinity. Two distinct composition maps representing the Ouzo domain characteristic of the presence of metastable nanoparticles have been established for each mixing method. Polymer nanoparticles are formed in the Ouzo domain according to a nucleation and growth (or aggregation) mechanism. The fast addition promotes a larger nucleation rate, thus favoring the formation of small and uniform particles. For the drop-by-drop addition, for which the polymer solubility gradually decreases, the composition trajectories systematically cross an intermediate unstable region between the solubility limit of the polymer and the Ouzo domain. This leads to heterogeneous nucleation as shown by the formation of larger and less stable particles. Particles formed in the Ouzo domain have semi-crystalline properties. The PCL melting point is decreased with the THF fraction trapped in particles in accordance with Flory's theory for melt crystallization. On the other hand, the degree of crystallinity is constant, around 20% regardless of the THF fraction. No difference between fast and slow addition could be detected on the semi-crystalline properties of the particles which emphasize that thermodynamic rather than kinetic factors drive the polymer crystallization in particles. The recovery of bulk PCL crystallinity after the removal of THF from particles tends to confirm this hypothesis.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: biodegradable polymer synthesis and properties · Advanced Polymer Synthesis and Characterization · Bone Tissue Engineering Materials

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Centre de Recherche Paul Pascal (CRPP), UMR CNRS 5031, Université de Bordeaux, 33600 Pessac, France

Laboratoire de Chimie des Polymères Organiques (LCPO), Université de Bordeaux, CNRS, Bordeaux INP, UMR 5629, 33600 Pessac, France

Laboratoire Léon Brillouin, CEA Saclay, 91191 Gif sur Yvette Cedex, France

Funding

Agence Nationale de la Recherche · Universit? de Bordeaux · R?gion Nouvelle-Aquitaine · Etat de France

References (52)

Show source-provided references
1. 10.1007/978-1-60761-609-2_1110.1007/978-1-60761-609-2_11 ↗
2. 10.1016/j.jconrel.2016.01.00410.1016/j.jconrel.2016.01.004 ↗
3. 10.1016/j.biotechadv.2013.08.01010.1016/j.biotechadv.2013.08.010 ↗
4. 10.1039/c3nr02176a10.1039/c3nr02176a ↗
5. 10.1002/anie.20140298610.1002/anie.201402986 ↗
6. 10.1021/jp101465c10.1021/jp101465c ↗
7. 10.1039/c4sm01461h10.1039/c4sm01461h ↗
8. 10.1021/ma981039f10.1021/ma981039f ↗
9. 10.1021/ma902680610.1021/ma9026806 ↗
10. 10.1039/b925666k10.1039/b925666k ↗
11. 10.1021/jp106610t10.1021/jp106610t ↗
12. 10.1002/1521-3773(20011203)40:23<4330::aid-anie4330>3.0.co;2-w10.1002/1521-3773(20011203)40:23<4330::aid-anie4330>3.0.co;2-w ↗
13. 10.1016/j.jcis.2008.03.03310.1016/j.jcis.2008.03.033 ↗
14. 10.1016/j.nantod.2016.04.00610.1016/j.nantod.2016.04.006 ↗
15. 10.1021/la061122t10.1021/la061122t ↗
16. 10.1021/la803000e10.1021/la803000e ↗
17. 10.1016/j.cis.2011.02.00510.1016/j.cis.2011.02.005 ↗
18. 10.1103/physrevlett.91.11830210.1103/physrevlett.91.118302 ↗
19. 10.1016/j.colsurfa.2013.08.05610.1016/j.colsurfa.2013.08.056 ↗
20. 10.1016/j.ejps.2004.09.01110.1016/j.ejps.2004.09.011 ↗
21. 10.1016/s0168-3659(03)00367-510.1016/s0168-3659(03)00367-5 ↗
22. 10.1016/j.ijpharm.2005.02.02610.1016/j.ijpharm.2005.02.026 ↗
23. 10.1021/bm050883s10.1021/bm050883s ↗
24. 10.1016/s0032-3861(99)00586-810.1016/s0032-3861(99)00586-8 ↗
25. 10.1016/j.progpolymsci.2010.04.00210.1016/j.progpolymsci.2010.04.002 ↗
26. 10.1039/c0sm00862a10.1039/c0sm00862a ↗
27. 10.1016/S0939-6411(98)00015-010.1016/S0939-6411(98)00015-0 ↗
28. 10.1051/jp2:199712810.1051/jp2:1997128 ↗
29. 10.1016/j.addr.2013.12.00910.1016/j.addr.2013.12.009 ↗
30. 10.1007/bf0065689610.1007/bf00656896 ↗
31. 10.1021/je00020a02610.1021/je00020a026 ↗
32. 10.1016/0032-3861(95)90934-t10.1016/0032-3861(95)90934-t ↗
33. 10.1016/0014-3057(72)90109-710.1016/0014-3057(72)90109-7 ↗
34. 10.1002/cphc.20040052710.1002/cphc.200400527 ↗
35. 10.1088/1742-6596/352/1/01204710.1088/1742-6596/352/1/012047 ↗
36. 10.1021/la026842o10.1021/la026842o ↗
37. 10.1016/j.colsurfa.2013.11.04510.1016/j.colsurfa.2013.11.045 ↗
38. 10.1021/la401905310.1021/la4019053 ↗
39. 10.1002/anie.20120711410.1002/anie.201207114 ↗
40. 10.1021/la400498j10.1021/la400498j ↗
41. 10.1021/la034173o10.1021/la034173o ↗
42. Flory P. J. · 1953
43. Belfiore L. A. · 201010.1002/9780470551592 ↗
44. 10.1039/b820162p10.1039/b820162p ↗
45. 10.1016/j.polymer.2015.12.02410.1016/j.polymer.2015.12.024 ↗
46. 10.1016/j.polymdegradstab.2007.02.01910.1016/j.polymdegradstab.2007.02.019 ↗
47. 10.1021/jp064383k10.1021/jp064383k ↗
48. 10.1021/nn405914g10.1021/nn405914g ↗
49. Huang Y.-p. · Chin. J. Polym. Sci. · 2002 · 20 · 45
50. 10.1016/j.ijpharm.2009.09.02310.1016/j.ijpharm.2009.09.023 ↗
51. 10.1002/mats.20039000310.1002/mats.200390003 ↗
52. 10.1023/a:101019532179710.1023/a:1010195321797 ↗